INCREASED RATES OF MYOFIBRILLAR PROTEIN BREAKDOWN IN MUSCLE-WASTING DISEASES

被引：41

作者：

WARNES, DM ^{[1
]}

TOMAS, FM ^{[1
]}

BALLARD, FJ ^{[1
]}

机构：

[1] CSIRO, DIV HUMAN NUTR, ADELAIDE, SA 5000, AUSTRALIA

来源：

MUSCLE & NERVE | 1981年 / 4卷 / 01期

关键词：

D O I：

10.1002/mus.880040111

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：62 / 66

页数：5

共 50 条

[1] MEDIATION OF THE CALCIUM SIGNAL BY CALCIMEDINS - IMPLICATIONS IN MUSCLE-WASTING DISEASES
MOORE, PB
ROISEN, FN
BIRD, JWC
[J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1987, 494 : 138 - 142
[2] MYOFIBRILLAR PROTEIN CATABOLIC RATES IN CIRRHOTIC-PATIENTS WITH AND WITHOUT MUSCLE WASTING
ZOLI, M
MARCHESINI, G
DONDI, C
BIANCHI, GP
PISI, E
[J]. CLINICAL SCIENCE, 1982, 62 (06): : 683 - 686
[3] Therapeutic Implications of miRNAs for Muscle-Wasting Conditions
Yedigaryan, Laura
Sampaolesi, Maurilio
[J]. CELLS, 2021, 10 (11)
[4] Cachexia: Inhibiting FAO rescues muscle-wasting
Crunkhorn S.
[J]. Nature Reviews Drug Discovery, 2016, 15 (6) : 384 - 384
[5] Targeting myostatin for therapies against muscle-wasting disorders
Tsuchida, Kunihiro
[J]. CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2008, 11 (04) : 487 - 494
[6] CIRCULATING ANTIBODIES IN POLYMYOSITIS + OTHER MUSCLE-WASTING DISORDERS
CASPARY, EA
STERN, GM
GUBBAY, SS
[J]. LANCET, 1964, 2 (736): : 941 - &
[7] Mighty mice hold key to muscle-wasting disease
Hooper, R
[J]. NEW SCIENTIST, 2005, 188 (2529) : 11 - 11
[8] Potential of antisense oligonucleotides for the treatment of muscle-wasting disease
Bruce, Isaac
[J]. FUTURE MEDICINAL CHEMISTRY, 2012, 4 (06) : 710 - 710
[9] LYMPHOCYTE STIMULATION WITH MUSCLE HOMOGENATE IN POLYMYOSITIS AND OTHER MUSCLE-WASTING DISORDERS
SAUNDERS, M
KNOWLES, M
CURRIE, S
[J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1969, 32 (06): : 569 - &
[10] MINI-GENE INJECTION PREVENTS MUSCLE-WASTING DISEASE
WEBB, J
[J]. NEW SCIENTIST, 1993, 139 (1888) : 8 - 9

← 1 2 3 4 5 →